Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra

Experimental Neurology

Volumn 248, Issue , 2013, Pages 541-545

  Garcia Reitboeck, Pablo ^a   Anichtchik, Oleg ^a   Dalley, Jeffrey W ^b,c   Ninkina, Natalia ^d   Tofaris, George K ^a   Buchman, Vladimir L ^d   Spillantini, Maria Grazia ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Dept of Psychiatry ^*  (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Synuclein; Dopaminergic; Embryonic development; Parkinson's disease; Transgenic mouse

Indexed keywords

ALPHA SYNUCLEIN;

ALPHA SYNUCLEIN GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO DEVELOPMENT; GENE; GENE DELETION; HETEROZYGOSITY; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA PARS COMPACTA;

Α-SYNUCLEIN; DOPAMINERGIC; EMBRYONIC DEVELOPMENT; PARKINSON'S DISEASE; TRANSGENIC MOUSE;

ALPHA-SYNUCLEIN; ANIMALS; CELL COUNT; DOPAMINERGIC NEURONS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SUBSTANTIA NIGRA;

EID: 84883147939     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.07.015     Document Type: Article

References (32)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
2. Al-Wandi A., Ninkina N., Millership S., Williamson S.J.M., Jones P.A., Buchman V.L. Absence of α-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol. Aging 2010, 31:796-804.
3. Anwar S., Peters O., Millership S., Ninkina N., Doig N., Connor-Robson N., Threlfell S., Kooner G., Deacon R.M., Bannerman D.M., Bolam J.P., Chandra S.S., Cragg S.J., Wade-Martins R., Buchman V.L. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. J. Neurosci. 2011, 31:7264-7274.
4. Bryant C.D., Zhang N.N., Sokoloff G., Fanselow M.S., Ennes H.S., Palmer A.A., McRoberts J.A. Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J. Neurogenet. 2008, 22:315-331.
5. Burre J., Sharma M., Tsetsenis T., Buchman V., Etherton M.R., Sudhof T.C. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010, 329:1663-1667.
6. Chandra S., Gallardo G., Fernandez-Chacon R., Schluter O.M., Sudhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005, 123:383-396.
7. Darios F., Ruiperez V., Lopez I., Villanueva J., Gutierrez L.M., Davletov B. Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep. 2010, 11:528-533.
8. Garcia-Reitboeck P., Anichtchik O., Bellucci A., Iovino M., Ballini C., Fineberg E., Ghetti B., Della C.L., Spano P., Tofaris G.K., Goedert M., Spillantini M.G. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 2010, 133:2032-2044.
9. Gasser T. Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects. Prog. Brain Res. 2010, 183:3-20.
10. George J.M., Jin H., Woods W.S., Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995, 15:361-372.
11. Greten-Harrison B., Polydoro M., Morimoto-Tomita M., Diao L., Williams A.M., Nie E.H., Makani S., Tian N., Castillo P.E., Buchman V.L., Chandra S.S. alpha/beta/gamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:19573-19578.
12. Hsu L.J., Mallory M., Xia Y., Veinbergs I., Hashimoto M., Yoshimoto M., Thal L.J., Saitoh T., Masliah E. Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. J. Neurochem. 1998, 71:338-344.
13. Kadkhodaei B., Ito T., Joodmardi E., Mattsson B., Rouillard C., Carta M., Muramatsu S., Sumi-Ichinose C., Nomura T., Metzger D., Chambon P., Lindqvist E., Larsson N.G., Olson L., Bjorklund A., Ichinose H., Perlmann T. Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J. Neurosci. 2009, 29:15923-15932.
14. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
15. Michell A.W., Tofaris G.K., Gossage H., Tyers P., Spillantini M.G., Barker R.A. The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease. Cell Transplant. 2007, 16:461-474.
16. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di I.G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
17. Robertson D.C., Schmidt O., Ninkina N., Jones P.A., Sharkey J., Buchman V.L. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. J. Neurochem. 2004, 89:1126-1136.
18. Scott D., Roy S. alpha-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J. Neurosci. 2012, 32:10129-10135.
19. Simon H.H., Saueressig H., Wurst W., Goulding M.D., O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 2001, 21:3126-3134.
20. Simon H.H., Bhatt L., Gherbassi D., Sgado P., Alberi L. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann. N. Y. Acad. Sci. 2003, 991:36-47.
21. Singleton A.B.., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
22. Specht C.G., Schoepfer R. Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci. 2001, 2:11.
23. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
24. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6469-6473.
25. Tatton W.G., Greenwood C.E., Verrier M.C., Holland D.P., Kwan M.M., Biddle F.E. Different rates of age-related loss for four murine monoaminergic neuronal populations. Neurobiol. Aging 1991, 12:543-556.
26. Thomas B., Mandir A.S., West N., Liu Y., Andrabi S.A., Stirling W., Dawson V.L., Dawson T.M., Lee M.K. Resistance to MPTP-neurotoxicity in a-synuclein knowckout mice is complemented by human a-synuclein and associated with increased b-synuclein and Akt activation. PLoS One 2011, 6(1):e16706.
27. Tofaris G.K., Garcia-Reitboek R.P., Humby T., Lambourne S.L., O'Connell M., Ghetti B., Gossage H., Emson P.C., Wilkinson L.S., Goedert M., Spillantini M.G. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J. Neurosci. 2006, 26:3942-3950.
28. Wallen A., Zetterstrom R.H., Solomin L., Arvidsson M., Olson L., Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 1999, 253:737-746.
29. West M.J. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 1999, 22:51-61.
30. Winner B., Lie D.C., Rockenstein E., Aigner R., Aigner L., Masliah E., Kuhn H.G., Winkler J. Human wild-type alpha-synuclein impairs neurogenesis. J. Neuropathol. Exp. Neurol. 2004, 63:1155-1166.
31. Winner B., Regensburger M., Schreglmann S., Boyer L., Prots I., Rockenstein E., Mante M., Zhao C., Winkler J., Masliah E., Gage F.H. Role of alpha-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus. J. Neurosci. 2012, 32:16906-16916.
32. Zhong S.C., Luo X., Chen X.S., Cai Q.Y., Liu J., Chen X.H., Yao Z.X. Expression and subcellular location of alpha-synuclein during mouse-embryonic development. Cell. Mol. Neurobiol. 2010, 30:469-482.